MaxLife’s lowest advertised monthly prices are not its smallest first payments. The compounded semaglutide Starter Kit is advertised at $89 per month for three months, but collects $267 now; compounded tirzepatide is advertised at $120 per month for three months, with $360 collected now. Subsequent advertised charges rise to $155 and $195 per month, respectively. Separate monthly options are available, so the prepaid introductory offer is a choice—not a universal enrollment requirement.
That distinction sets the agenda for this documentary review: what leaves your account first, what the subscription includes, and what could change afterward. Sources consulted October 19, 2026, describe a telehealth platform connecting patients with independent clinicians and partner pharmacies, not a healthcare practice operated by MaxLife itself. The documents provide useful prices and process details, but contain unresolved differences concerning cancellation, state availability, pharmacy assignments and promotional guarantees. Licensing and service claims were not independently verified.
At a glance
- Semaglutide introductory payment
- Compounded semaglutide Starter Kit: $89/month for three months, billed $267 now, then $155/month. A separate $155 monthly plan is advertised.Sources: [7]
- Tirzepatide introductory payment
- Compounded tirzepatide Starter Kit: $120/month for three months, billed $360 now, then $195/month. A separate $195 monthly plan is advertised.Sources: [4]
- Advertised inclusions
- MaxLife says program pricing includes medication, supplies, provider-guided care and priority shipping.Sources: [3]
- Renewal and cancellation
- Subscriptions renew automatically at then-current rates. The FAQ requires cancellation notice at least 30 days before the next billing period; the terms direct requests to cs@maxlife.com.
- Payment and insurance
- The terms require cash-basis payment and say MaxLife will not submit reimbursement claims to federal or state health insurance programs.Sources: [6]
Start with the amount collected, not the monthly headline
MaxLife’s product pages separate a discounted Starter Kit from an ordinary monthly plan. For compounded semaglutide, the introductory rate is $89 per month for three months, collected as $267 upfront, followed by $155 monthly. For compounded tirzepatide, it is $120 per month for three months, collected as $360 upfront, followed by $195 monthly. MaxLife advertises total savings of $198 and $225, respectively; those are the company’s promotional figures, not an independently calculated comparison.
The monthly alternatives are $155 for compounded semaglutide and $195 for compounded tirzepatide, each labeled “Guaranteed Fee.” The supplied documentation does not expressly identify semaglutide’s administration route. Tirzepatide is presented as self-injectable, without specifying the anatomical route in this evidence. Neither a three-month price period nor its upfront collection establishes a particular vial count, dispensed quantity or minimum treatment commitment.
The practical comparison is therefore cash flow as well as price. Someone choosing the introductory package authorizes a larger first charge than the headline monthly equivalent; someone selecting the monthly alternative takes a different payment path. Our guide to reading the first GLP-1 payment explains that distinction. Before checkout, obtain the exact product, formulation, presentation, initial charge and next billing date in one written quote rather than relying on the promotional banner.
| Option | Initial advertised charge | Subsequent advertised charge |
|---|---|---|
| Compounded semaglutide Starter Kit | $267 now; advertised as $89/month for three months | $155/month |
| Compounded semaglutide monthly plan | $155/month | $155/month; renewal terms apply |
| Compounded tirzepatide Starter Kit | $360 now; advertised as $120/month for three months | $195/month |
| Compounded tirzepatide monthly plan | $195/month | $195/month; renewal terms apply |
What the advertised bundle covers—and what it leaves open
MaxLife says its program price includes medication, supplies, provider-guided care and priority shipping. The tirzepatide page is more specific: every plan includes medication, clinician review, ongoing messaging for prescription adjustments and side-effect support, and free overnight shipping. Those are meaningful advertised inclusions because they describe more than a medication purchase. They remain provider representations, however, rather than independently observed service performance or a complete schedule of every possible charge.
The follow-up description includes ongoing provider messaging and clinically directed prescription adjustments. Yet the supplied materials do not establish support hours, message response targets, mandatory consultation frequency, laboratory requirements or Spanish-language availability. They also do not settle whether any separately required testing would be included. A useful written estimate should distinguish services explicitly bundled into the subscription from services whose price or availability remains undocumented; our included-costs guide provides that framework.
Two clauses qualify the flat-price message. The terms allow sales taxes and other government-imposed fees outside the subscription price. Separately, MaxLife says an approved higher prescription dose can lead to adjustments to both the prescription and membership. That does not establish a specific surcharge, but it prevents treating “Guaranteed Fee” as conclusive proof that every future clinical change costs the same. Ask which changes, if any, alter the amount billed.
Renewal prices and the limits of the guarantees
The Starter Kit pages explicitly identify the post-introductory prices: $155 per month for compounded semaglutide and $195 for compounded tirzepatide. These figures should not be hidden behind a general statement that future costs are unknown. However, the subscription terms also provide for automatic renewal at the frequency shown on the subscription page—or monthly if none is designated—and at then-current rates. The listed renewal price is therefore not documentation of an indefinite price lock.
MaxLife also promotes a free consultation with no upfront payment, a six-month results guarantee, and a lowest-price and price-match guarantee. The supplied promotional block does not explain the guarantees’ full conditions. The free-consultation message should not be confused with the Starter Kit’s payment structure: an introductory conversation can require no payment while a subsequently purchased package still collects three months upfront. Ask when the payment authorization becomes effective.
The results guarantee needs particular clarification because another MaxLife page says no specific result is guaranteed and that individual experiences vary. These statements do not supply a usable refund formula, eligibility rule or claim deadline. Likewise, the price-match slogan does not identify qualifying competitors or matching conditions here. Treat these as offers requiring written terms, rather than amounts to subtract from a budget. Our guide to introductory offers and renewal prices explains how to separate them.
Cancellation is a deadline, not a refund promise
The FAQ says MaxLife does not require a long-term contract and permits cancellation with notice at least 30 days before the next billing period begins. The terms instruct customers to email cs@maxlife.com requesting cancellation 30 days before the intended cancellation date. Those formulations are not identical. For budgeting, the important task is to have MaxLife confirm the effective cancellation date and whether another charge will occur, rather than assuming an email stops billing immediately.
Another provision addresses plans with preset commitment periods and a predetermined early-termination fee specified in the offer. This does not prove that every Starter Kit has such a commitment or fee. It does mean the general no-long-term-contract message is not enough to resolve the terms of a particular purchase. The supplied materials also contain conflicting descriptions of access after cancellation: continued access through a paid period versus possible immediate deactivation and loss of access to clinicians and medication.
Refund boundaries are clearer in several respects. Subscription payments are generally nonrefundable, with no credits for partially used periods; medication costs are also described as nonrefundable. Physical items cannot be returned, refunded or exchanged, and shipped orders cannot be canceled. An express exception promises repayment of amounts paid for services if a person is deemed ineligible. No bank-arrival timetable is established. The distinction between stopping future charges and recovering money is central to our cancellation and refunds guide.
Self-pay, benefit accounts and geographic restrictions
MaxLife advertises that insurance is not required. Its terms go further by describing purchases as cash-basis transactions and saying it will not submit claims for reimbursement to federal or state health insurance programs. This is not evidence that private insurance is accepted, billed or reimbursed. The supplied documents do not establish a complete private-insurance policy, so readers should not budget on an insurer paying part of the advertised subscription without separate confirmation.
Benefit-account language is also uneven. The homepage presents FSA/HSA eligibility broadly, while the semaglutide page says expenses may qualify depending on the plan’s rules and advises checking with the plan administrator. The conditional wording is the more useful budgeting standard: do not treat potential FSA or HSA payment or reimbursement as settled. Obtain the documentation your administrator needs and confirm eligibility before assuming those funds can cover a particular MaxLife purchase.
Geographic availability requires similar care. MaxLife’s FAQ advertises service in all 50 states, but its terms warn that certain services are unavailable in some states. The terms require users to be at least 18 and refer to residence in the United States or its territories, while another provision limits services to users located in the United States. These statements do not confirm every medication, pharmacy or consultation option at every address.
Who evaluates the patient—and who sells the subscription
Maxlife Technologies Inc. describes itself as a patient-management platform working with independent physicians and practitioners. Its terms explicitly say the company is not a healthcare provider: the customer relationship is with MaxLife, while the provider-patient relationship is with the treating professional. That separation matters when asking who controls prescribing, who handles subscription billing and whom to contact when either part of the arrangement fails. A clinician should not automatically be described as a physician.
The online intake requests health history, goals and current medications. MaxLife’s experiences page estimates about two minutes for the form, while other pages describe an approximately five-minute initial process. A clinician may request more information or require a telehealth visit before deciding whether to prescribe. Where a state requires a TeleVisit, MaxLife says a clinician will contact the patient to arrange a two-way audiovisual appointment. Completing intake does not guarantee a prescription.
The tirzepatide page says eligibility depends on health history and the clinician’s decision; not everyone qualifies. The supplied documents do not name the medical groups or individual treating clinicians, provide their license numbers, or specify admission BMI thresholds and laboratory requirements. MaxLife’s usual approval estimate of within 24 hours is a provider claim, not a guaranteed decision time or delivery deadline. These gaps are reasons to clarify responsibility before paying, not evidence that an evaluation never occurs.
Pharmacy assignment and shipping affect the value of the bundle
The product pages identify Hallandale Pharmacy, Red Rock Pharmacy and Strive Pharmacy among the partners preparing products. The homepage gives a different, longer list, including Dirx, Southend, “Hallendale,” Red Rock, Advanced, Perfect Rx, Health Wealth, Quaker Community, VLS and NewLife Rx. MaxLife says the dispensing pharmacy depends on location, prescription and availability. The spelling difference and nonmatching lists leave the individual assignment unresolved; pharmacy licensing and authorization were not independently verified.
Shipping frequency is not necessarily the same as billing frequency. MaxLife says some patients receive monthly shipments and others receive shipments every 90 days, depending on billing period and prescription. A prepaid three-month package therefore does not, by itself, establish one shipment containing a specified three-month quantity. Confirm the assigned pharmacy, exact formulation, amount dispensed, supplies and shipment schedule. Those details determine what the upfront payment actually purchases, beyond its advertised duration.
MaxLife advertises priority shipping and, on the tirzepatide page, free overnight shipping. It separately estimates two to three business days for pharmacy processing and dispatch when medication is in stock, and its terms guarantee no specific arrival date or time. It describes insulated packaging with ice and says the package can remain boxed for up to 72 hours. That packaging claim does not override FDA advice: do not use an injectable GLP-1 drug arriving warm or inadequately refrigerated; contact the provider or pharmacy.
What the price cannot establish about the treatment
The documented offers concern compounded semaglutide and compounded tirzepatide, not proof of access to an FDA-approved branded product. FDA approval attaches to a specific product, not a platform or pharmacy. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality. Nonapproval alone does not demonstrate clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy.
MaxLife itself states that results from cited studies of specific FDA-approved products have not been established for compounded semaglutide or tirzepatide. Its testimonials and promotional guarantees therefore cannot establish the expected outcome from this subscription. The supplied materials also do not establish a specific clinical advantage for the advertised vitamin-related claims or settle which additives an individual would receive. Ask for the actual formulation rather than assuming every pharmacy supplies an identical preparation.
A complete cost discussion should include what follow-up is available if treatment is poorly tolerated or needs to change. NIDDK describes medication choice as a discussion of benefits, side effects, health conditions, other medicines and costs; treatment duration depends on response and tolerability. FDA has also received reports of measuring or administration errors involving compounded drugs. Instructions should be clarified with the prescriber or pharmacist, not reconstructed from a review or inferred from a subscription price.
Questions & answers
Can I pay MaxLife monthly instead of prepaying for three months?
Yes. The product pages advertise separate monthly plans at $155 for compounded semaglutide and $195 for compounded tirzepatide. The lower introductory monthly equivalents require $267 or $360 upfront for the respective three-month Starter Kit. Confirm the selected option and first renewal date at checkout.
Does MaxLife’s price include the medicine and follow-up?
MaxLife says pricing includes medication, supplies, provider-guided care and priority shipping. It also advertises ongoing messaging for prescription adjustments and side-effect support. The documents do not establish message response times, laboratory costs or every possible additional service. Taxes and government-imposed fees can be outside the subscription price.
How do I cancel, and will I get money back?
The terms direct cancellation requests to cs@maxlife.com with 30 days’ notice; the FAQ specifies at least 30 days before the next billing period. Cancellation does not generally create a refund entitlement. Subscription and medication payments have nonrefundability provisions, while the terms expressly promise repayment for services if you are deemed ineligible.
Will MaxLife prescribe after I complete the online form?
Not necessarily. A clinician reviews the information and may request more details or a telehealth appointment before deciding. MaxLife explicitly says completing the form does not guarantee a prescription. Its terms require users to be at least 18, but the supplied evidence does not provide a complete set of clinical admission criteria.
Which pharmacy will send my medication, and how soon?
The documents do not establish an individual pharmacy assignment. MaxLife says it varies by location, prescription and availability. Pharmacy processing and dispatch average two to three business days when medication is stocked, according to the company. Advertised overnight shipping is not a promise of next-day arrival after enrollment, and the terms guarantee no specific delivery time.
Can I use insurance, an FSA or an HSA?
The terms describe cash-basis payment and no claims submitted to federal or state health insurance programs. Private-insurance billing is not established in the supplied documents. Although MaxLife advertises FSA/HSA eligibility, its semaglutide page makes payment or reimbursement conditional on plan rules. Confirm the specific expense with your administrator before relying on those funds.
Our assessment
MaxLife documents more pricing detail than a headline-only offer: both Starter Kit payments, subsequent monthly charges, monthly alternatives and several bundled services are stated. That makes the initial cash requirement reasonably legible. The weaker point is the boundary around future obligations. Then-current renewal rates, possible membership adjustments, a 30-day cancellation deadline and conflicting commitment language complicate the flat-price presentation. Before purchasing, obtain a written confirmation of the selected payment option, next charge, assigned pharmacy, dispensed formulation and quantity, and cancellation consequences. Request complete guarantee terms rather than treating promotional promises as budget protection. MaxLife’s documented offer is a self-pay platform arrangement for compounded medication and clinician-guided care; its price alone establishes neither clinical suitability nor the quality or outcome of that care.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.